Melvin Booth has been a member of our Board of Directors since August 2014 and was a member of the Board of Directors of our subsidiary Catalent Pharma Solutions, Inc. from July 2010 until September 2014. Most recently, Booth served as President and Chief Operating Officer of Medimmune, Inc. from 1998 through his retirement in 2003, and as a Director from 1998 through 2005. Prior to that, Booth was President, Chief Operating Officer and Director of Human Genome Sciences, Inc. from 1995 to 1998. Booth also served in a variety of senior leadership positions for Syntex Inc., including leading both Syntex Laboratories, Inc. and Syntex Pharmaceuticals Pacific. Booth also served as Lead Director for Millipore Corporation until its acquisition by Merck KGaA, and currently serves as Chairman of the Board for Mallinckrodt plc, Chairman of the Board for eResearchTechnology, Inc. and as a strategic advisor in life sciences for Genstar Capital. Booth holds an undergraduate degree and an honorary Ph.D. in Science from the Northwest Missouri State University.